# Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in Singapore

> **NCT04825262** · NA · COMPLETED · sponsor: **Singapore General Hospital** · enrollment: 74 (actual)

## Conditions studied

- Kidney Transplant Rejection
- Kidney Transplant; Complications

## Interventions

- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT04825262
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2024-01-16
- **Final completion:** 2024-04-09
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2024-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04825262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04825262, "Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in Singapore". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04825262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*